Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells

Muscle and Nerve

Volumn 26, Issue 5, 2002, Pages 644-653

  Langenbach, K J ^a   Rando, T A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

AKT; Apoptosis; Dystroglycan; Extracellular matrix; Muscular dystrophy

Indexed keywords

CASEIN KINASE I; CELL SURFACE RECEPTOR; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; LAMININ; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCLEROPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; MOUSE; MUSCULAR DYSTROPHY; MYOTUBE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; LAMININ; MEMBRANE GLYCOPROTEINS; MICE; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 0036842214     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10258     Document Type: Article

References (61)

1. 2+-calmodulin binds to the carboxyl-terminal domain of dystrophin. J Biol Chem 1996;271:6605-6610.
2. Beitner-Johnson D, Rust RT, Hsieh TC, Millhorn DE. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell Signal 2001;13:23-27.
3. Belkin AM, Smalheiser NR. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: Recruitment to focal adhesions is dependent upon extracellular ligands. Cell Adhes Commun 1996;4:281-296.
4. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001;3:1014-1019.
5. Brown SC, Fassati A, Popplewell L, Page AM, Henry MD, Campbell KP, Dickson G. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J Cell Sci 1999;112:209-216.
6. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995;376:599-602.
7. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 2001;152:1207-1218.
8. Campbell KP. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage. Cell 1995;80:675-679.
9. Cavaldesi M, Macchia G, Barca S, Defilippi P, Tarone G, Petrucci TC. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neurochem 1999;72:1648-1655.
10. Chardin P, Cussac D, Maignan S, Ducruix A. The Grb2 adaptor. FEBS Lett 1995;369:47-51.
11. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994;91:10148-10152.
12. Cohen MW, Jacobson C, Yurchenco PD, Morris GE, Carbonetto S. Laminin-induced clustering of dystroglycan on embryonic muscle cells: Comparison with agrin-induced clustering. J Cell Biol 1997;136:1047-1058.
13. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 2000;23:1456-1471.
14. Cohn RD, Mayer U, Saher G, Herrmann R, van der FA, Sonnenberg A, Sorokin L, Voit T. Secondary reduction of α7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. J Neurol Sci 1999;163:140-152.
15. 7B expression and caveolin-3 distribution. J Biol Chem 2002;277:4672-4679.
16. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev 1999;13:2905-2927.
17. Disatnik MH, Rando TA. Integrin-mediated muscle cell spreading. The role of protein kinase C in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem 1999;274:32486-32492.
18. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 1998;46:449-457.
19. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P. Non-muscle α-dystroglycan is involved in epithelial development. J Cell Biol 1995;130:79-91.
20. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;66:1121-1131.
21. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823.
22. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997;9:701-706.
23. Gullberg D, Tiger CF, Veiling T. Laminins during muscle development and in muscular dystrophies. Cell Mol Life Sci 1999;56:442-460.
24. Henry MD, Satz JS, Brakebusch C, Costell M, Gustafsson E, Fassler R, Campbell KP. Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organization. J Cell Sci 2001;114:1137-1144.
25. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J Cell Sci 1997;110:2873-2881.
26. Holt KH, Crosbie RH, Venzke DP, Campbell KP. Biosynthesis of dystroglycan: Processing of a precursor propeptide. FEBS Lett 2000;468:79-83.
27. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992;355:696-702.
28. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998;143:547-560.
29. Ilsley JL, Sudol M, Winder SJ. The interaction of dystrophin with β-dystroglycan is regulated by tyrosine phosphorylation. Cell Signal 2001;13:625-632.
30. Imamura M, Araishi K, Noguchi S, Ozawa E. A sarcoglycandystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 2000;9:3091-3100.
31. Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 2001;152:435-450.
32. James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ. Adhesion-dependent tyrosine phosphorylation of β-dystroglycan regulates its interaction with utrophin. J Cell Sci 2000;113:1717-1726.
33. Jiang BH, Zheng JZ, Vogt PK. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA 1998;95:14179-14183.
34. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 1996;271:19146-19151.
35. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-κB by the Akt/PKB kinase, Curr Biol 1999;9:601-604.
36. Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA, Birnbaum MJ, Scott PH, Lawrence Jr, JC, Roth RA. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 1998;273:11937-11943.
37. Kotani K, Ogawa W, Hino Y, Kitamura T, Ueno H, Sano W, Sutherland C, Granner DK, Kasuga M. Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Cλ do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 1999;274:21305-21312.
38. Matsumura K, Chiba A, Yamada H, Fukuta-Ohi H, Fujita S, Endo T, Kobata A, Anderson LV, Kanazawa I, Campbell KP, Shimizu T. A role of dystroglycan in schwannoma cell adhesion to laminin. J Biol Chem 1997;272:13904-13910.
39. Montanaro F, Lindenbaum M, Carbonetto S. α-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J Cell Biol 1999;145: 1325-1340.
40. Mukasa T, Momoi T, Momoi MY. Activation of caspase-3 apoptotic pathways in skeletal muscle fibers in laminin α2-deficient mice. Biochem Biophys Res Commun 1999;260:139-142.
41. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
42. Oak SA, Russo K, Petrucci TC, Jarrett HW. Mouse α1-syntrophin binding to Grb2: Further evidence of a role for syntrophin in cell signaling. Biochemistry 2001;40:11270-11278.
43. Ohlendieck K, Campbell KP. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 1991;115:1685-1694.
44. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1998;273:19929-19932.
45. Rando TA. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001;24:1575-1594.
46. Rando TA, Disatnik MH, Yu Y, Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 1998;8:14-21.
47. Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M. The WW domain of dystrophin requires EF-hands region to interact with β-dystroglycan. Biol Chem 1999;380:431-442.
48. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001;3:1009-1013.
49. Saito F, Masaki T, Kamakura K, Anderson LV, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumura K. Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells. J Biol Chem 1999;274:8240-8246.
50. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435-478.
51. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell 2000;100:293-296.
52. SonodaY, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 1999;274:10566-10570.
53. Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP. Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 2001;40:14585-14592.
54. Taverna D, Disatnik MH, Rayburn H, Bronson RT, Yang J, Rando TA, Hynes RO. Dystrophic muscle in mice chimeric for expression of α5 integrin. J Cell Biol 1998;143:849-859.
55. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998;281:1312-1316.
56. Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 1995;108:2197-2204.
57. Vachon PH, Loechel F, Xu H, Wewer UM, Engvall E. Merosin and laminin in myogenesis: Specific requirement for merosin in myotube stability and survival. J Cell Biol 1996;134:1483-1497.
58. Vachon PH, Xu H, Liu L, Loechel F, Hayashi Y, Arahata K, Reed JC, Wewer UM, Engvall E. Integrins (α7β1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 1997;100:1870-1881.
59. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997;6:831-841.
60. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995;270:11711-11714.
61. Yoshida T, Pan Y, Hanada H, Iwata Y, Shigekawa M. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J Biol Chem 1998;273:1583-1590.